Dotz Nano has shared a new research that finds its graphene quantum dots (GQDs) technology effective in treating brain injuries, strokes, multiple sclerosis and heart attacks. According to the company, the study demonstrated that these dots, manufactured from coal, can assist in fighting oxidative stress to assist in treating patients suffering from the serious conditions.
Led by the Company's scientific advisor, Professor James Tour, the study was conducted by five universities and research facilities including Rice University, with the findings covered by multiple medical publications.
“Carbon-based nanomaterials are known to be excellent scavengers of reactive oxygen species, or ‘free radicals’, which are often a contributing factor for stroke, cardiovascular disease and cancer,” Dotz product development director Dr. Yoni Engel explained. “The research by Rice University and its research partners demonstrates that coal-based low toxicity GQDs can be successfully used to uncover diseases and fight oxidative stress in living mice,” he said.
Dotz Nano also shared that it is engaging with the medical industry and academic leaders to progress the possible use of its GQD products in biomedical applications. The Company said it has reached commercial production capacity and is now engaging with medical entities to commercialize the technology.
In addition, Dotz chief executive officer Uzi Breier said the company is actively seeking commercial partnership opportunities within the medical market for both its biomedical and anti-counterfeiting technologies.
“This new study highlights the promising effect of GQDs in treating a range of serious medical conditions and Dotz has the manufacturing capability to cost-effectively cater to future commercial requirements,” Mr. Breier said.